Literature DB >> 27046792

Characterization of cytoprotective and toxic properties of iron chelator SIH, prochelator BSIH and their degradation products.

Hana Jansová1, Jan Bureš1, Miloslav Macháček1, Pavlína Hašková1, Anna Jirkovská1, Jaroslav Roh1, Qin Wang2, Katherine J Franz2, Petra Kovaříková1, Tomáš Šimůnek3.   

Abstract

Free cellular iron catalyzes the formation of toxic hydroxyl radicals and therefore chelation of iron could be a promising therapeutic approach in pathological states associated with oxidative stress. Salicylaldehyde isonicotinoyl hydrazone (SIH) is a strong intracellular iron chelator with well documented potential to protect against oxidative damage both in vitro and in vivo. Due to the short biological half-life of SIH and risk of toxicity due to iron depletion, boronate prochelator BSIH has been designed. BSIH cannot bind iron until it is activated by certain reactive oxygen species to active chelator SIH. The aim of this study was to examine the toxicity and cytoprotective potential of BSIH, SIH, and their decomposition products against hydrogen peroxide-induced injury of H9c2 cardiomyoblast cells. Using HPLC, we observed that salicylaldehyde was the main decomposition products of SIH and BSIH, although a small amount of salicylic acid was also detected. In the case of BSIH, the concentration of formed salicylaldehyde consistently exceeded that of SIH. Isoniazid and salicylic acid were not toxic nor did they provide any antioxidant protective effect in H9c2 cells. In contrast, salicylaldehyde was able to chelate intracellular iron and significantly preserve cellular viability and mitochondrial inner membrane potential induced by hydrogen peroxide. However it was consistently less effective than SIH. The inherent toxicities of salicylaldehyde and SIH were similar. Hence, although SIH - the active chelating agent formed following the BSIH activation - undergoes rapid hydrolysis, its principal decomposition product salicylaldehyde accounts markedly for both cytoprotective and toxic properties.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Boronyl salicylaldehyde isonicotinoyl hydrazone (BSIH); Iron chelation; Prochelator; Salicylaldehyde; Salicylaldehyde isonicotinoyl hydrazone (SIH)

Mesh:

Substances:

Year:  2016        PMID: 27046792      PMCID: PMC4889448          DOI: 10.1016/j.tox.2016.03.004

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  35 in total

1.  Comparison of clinically used and experimental iron chelators for protection against oxidative stress-induced cellular injury.

Authors:  Petra Bendova; Eliska Mackova; Pavlina Haskova; Anna Vavrova; Eduard Jirkovsky; Martin Sterba; Olga Popelova; Danuta S Kalinowski; Petra Kovarikova; Katerina Vavrova; Des R Richardson; Tomas Simunek
Journal:  Chem Res Toxicol       Date:  2010-06-21       Impact factor: 3.739

2.  c-Jun DNAzymes inhibit myocardial inflammation, ROS generation, infarct size, and improve cardiac function after ischemia-reperfusion injury.

Authors:  Xiao Luo; Hong Cai; Jun Ni; Ravinay Bhindi; Harry C Lowe; Colin N Chesterman; Levon M Khachigian
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-07-10       Impact factor: 8.311

3.  Iron chelation protects the retinal pigment epithelial cell line ARPE-19 against cell death triggered by diverse stimuli.

Authors:  Nina Lukinova; Jared Iacovelli; Tzvete Dentchev; Natalie Wolkow; Allan Hunter; Defne Amado; Gui-Shuang Ying; Janet R Sparrow; Joshua L Dunaief
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-01-31       Impact factor: 4.799

4.  H2S ameliorates oxidative and proteolytic stresses and protects the heart against adverse remodeling in chronic heart failure.

Authors:  Paras K Mishra; Neetu Tyagi; Utpal Sen; Srikanth Givvimani; Suresh C Tyagi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-11-20       Impact factor: 4.733

5.  Investigation of the stability of aromatic hydrazones in plasma and related biological material.

Authors:  Petra Kovaríková; Zlata Mrkvicková; Jirí Klimes
Journal:  J Pharm Biomed Anal       Date:  2008-01-16       Impact factor: 3.935

6.  Protective effects of purified safflower extract on myocardial ischemia in vivo and in vitro.

Authors:  Shu-Yan Han; Hai-Xia Li; Xu Ma; Ke Zhang; Zhi-Zhong Ma; Peng-Fei Tu
Journal:  Phytomedicine       Date:  2009-04-24       Impact factor: 5.340

7.  Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone.

Authors:  T Simůnek; M Sterba; O Popelová; H Kaiserová; M Adamcová; M Hroch; P Hasková; P Ponka; V Gersl
Journal:  Br J Pharmacol       Date:  2008-06-09       Impact factor: 8.739

Review 8.  Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents.

Authors:  D R Richardson; D S Kalinowski; S Lau; P J Jansson; D B Lovejoy
Journal:  Biochim Biophys Acta       Date:  2008-04-27

9.  Neutral red uptake assay for the estimation of cell viability/cytotoxicity.

Authors:  Guillermo Repetto; Ana del Peso; Jorge L Zurita
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

10.  Iron prochelator BSIH protects retinal pigment epithelial cells against cell death induced by hydrogen peroxide.

Authors:  Louise K Charkoudian; Tzvete Dentchev; Nina Lukinova; Natalie Wolkow; Joshua L Dunaief; Katherine J Franz
Journal:  J Inorg Biochem       Date:  2008-08-24       Impact factor: 4.155

View more
  6 in total

1.  The hydrolytic susceptibility of prochelator BSIH in aqueous solutions.

Authors:  Qin Wang; Katherine J Franz
Journal:  Bioorg Med Chem Lett       Date:  2017-07-08       Impact factor: 2.823

2.  Stimulus-Responsive Prochelators for Manipulating Cellular Metals.

Authors:  Qin Wang; Katherine J Franz
Journal:  Acc Chem Res       Date:  2016-10-17       Impact factor: 22.384

3.  Cardioprotective effects of iron chelator HAPI and ROS-activated boronate prochelator BHAPI against catecholamine-induced oxidative cellular injury.

Authors:  Pavlína Hašková; Hana Jansová; Jan Bureš; Miloslav Macháček; Anna Jirkovská; Katherine J Franz; Petra Kovaříková; Tomáš Šimůnek
Journal:  Toxicology       Date:  2016-10-12       Impact factor: 4.221

4.  Modifying aroylhydrazone prochelators for hydrolytic stability and improved cytoprotection against oxidative stress.

Authors:  Qin Wang; Katherine J Franz
Journal:  Bioorg Med Chem       Date:  2018-11-05       Impact factor: 3.641

5.  Examination of diverse iron-chelating agents for the protection of differentiated PC12 cells against oxidative injury induced by 6-hydroxydopamine and dopamine.

Authors:  Pavlína Hašková; Lenka Applová; Hana Jansová; Pavel Homola; Katherine J Franz; Kateřina Vávrová; Jaroslav Roh; Tomáš Šimůnek
Journal:  Sci Rep       Date:  2022-06-13       Impact factor: 4.996

Review 6.  Potential Treatment of Retinal Diseases with Iron Chelators.

Authors:  Wanting Shu; Joshua L Dunaief
Journal:  Pharmaceuticals (Basel)       Date:  2018-10-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.